The SGLT2 inhibitor Empagliflozin promotes post-stroke functional recovery in diabetic mice

Ellen Vercalsteren, Dimitra Karampatsi, Carolina Buizza, Thomas Nyström, Thomas Klein, Gesine Paul-Visse, Cesare Patrone, Vladimer Darsalia

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'The SGLT2 inhibitor Empagliflozin promotes post-stroke functional recovery in diabetic mice'. Together they form a unique fingerprint.

Medicine and Dentistry

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science